Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc > VPH: VALEO PHARMA offers COVID-19 product for immune support

<< Previous

Bullboard Posts

Next >>

Post by Royal10on Jan 05, 2022 10:17am

302 Views

Post# 34284817

VPH: VALEO PHARMA offers COVID-19 product for immune support

Please read this very important news that should be very beneficial for VPH shareholders.
The new product: HESPERCO • Clinical study yields encouraging results that hesperidin may help reduce COVID-19 associated symptoms.
HESPERCO is NOW AVAILABLE AT LOBLAWS.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale